Regen BioPharma Inc (RGBP)

[art35]

OTCShotCaller
6/12/22, 08:03 PM
@Kreenday - Well said! The only way we're going to move forward from here is:
1). funding for the current Fast Track IND to enter clinical trials which is in the Multi Million Dollar Range (provided it's been approved by the FDA which we don't have conformation yet);
2). Merger Acquisition/Buy Out. These are the ONLY options at this point. Also there's no way possible for dilution to come anywhere close to providing the required capitalization of clinical trials which is in the $80 Million Dollar range, and this is a conservative estimate. This amount of money must come from a "Liquid Cash" source where draw down on demand can occur.

IMO, the ONLY option I see Dr. Koos has is a Buy Out/Merger Acquisition
If he comes back next time with anything other than this, such as another "deal" like the Canary-Weill proposal, that won't be a good sign. I would real that as a stall. So at this point we need to know if the FDA has approved the IND and the funding source for clinical trials